Consolidated Statements of Cash Flows - USD ($) $ in Millions		6 Months Ended
		Jul. 31, 2016	Aug. 02, 2015
OPERATING ACTIVITIES
Net Income		$ 322.1	$ 216.3
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization		153.2	124.0
Equity in net loss (income) of unconsolidated affiliates		0.5	(8.6)
Deferred taxes		(3.8)	(0.8)
Stock-based compensation expense		19.5	20.4
Impairment of long-lived assets		0.0	1.6
Debt modification and extinguishment costs		15.8	0.0
Gain to write-up equity investment in joint venture to fair value		(153.1)	0.0
Changes in operating assets and liabilities:
Trade receivables, net		97.7	106.0
Inventories, net		(55.6)	(164.6)
Accounts payable, accrued expenses and deferred revenue		(15.9)	(45.0)
Prepaid expenses		0.8	16.4
Other, net		29.1	90.1
Net cash provided by operating activities		408.7	323.0
INVESTING ACTIVITIES(1)
Business acquisitions, net of cash acquired		(157.7)	0.0
Purchase of property, plant and equipment		(102.8)	(100.9)
Proceeds from sale of building		16.7	0.0
Contingent purchase price payments		(25.2)	(23.9)
Change in restricted cash		0.0	20.2
Investments in unconsolidated affiliates		(1.5)	(22.6)
Net cash used by investing activities	[1]	(270.5)	(127.2)
FINANCING ACTIVITIES(1)
Net payments on short-term borrowings		(6.5)	(0.4)
Proceeds from 2016 facilities, net of related fees		571.1	0.0
Repayment of Term Loan B under 2014 facilities		(582.0)	0.0
Repayment of 2016/2014 facilities		(201.2)	(165.7)
Proceeds from 3 5/8% senior notes, net of related fees		389.6	0.0
Net proceeds from settlement of awards under stock plans		10.3	5.3
Excess tax benefits from awards under stock plans		0.5	3.4
Cash dividends		(9.2)	(9.4)
Acquisition of treasury shares		(133.9)	(26.8)
Payments of capital lease obligations		(3.6)	(3.8)
Net cash provided (used) by financing activities	[1]	35.1	(197.4)
Effect of exchange rate changes on cash and cash equivalents		12.0	(11.0)
Increase (decrease) in cash and cash equivalents		185.3	(12.6)
Cash and cash equivalents at beginning of period		556.4	479.3
Cash and cash equivalents at end of period		$ 741.7	$ 466.7

[1] See Note 17 for information on Noncash Investing and Financing Transactions.